Literature DB >> 33276123

DNA alternate polymerase PolB mediates inhibition of type III secretion in Pseudomonas aeruginosa.

Shubham Chakravarty1, Layla Ramos-Hegazy1, Abigail Gasparovic1, Gregory G Anderson2.   

Abstract

Opportunistic pathogen Pseudomonas aeruginosa uses a variety of virulence factors to cause acute and chronic infections. We previously found that alternate DNA polymerase gene polB inhibits P. aeruginosa pyocyanin production. We investigated whether polB also affects T3SS expression. polB overexpression significantly reduced T3SS transcription and repressed translation of the master T3SS regulator ExsA, while not affecting exsA mRNA transcript abundance. Further, polB does not act through previously described genetic pathways that post-transcriptionally regulate ExsA. Our results show a novel T3SS regulatory component which may lead to development of future drugs to target this mechanism.
Copyright © 2020 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Pseudomonas aeruginosa; Stress; Type III secretion

Mesh:

Substances:

Year:  2020        PMID: 33276123      PMCID: PMC8084926          DOI: 10.1016/j.micinf.2020.11.004

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  25 in total

1.  Activation of the Pseudomonas aeruginosa AlgU regulon through mucA mutation inhibits cyclic AMP/Vfr signaling.

Authors:  Adriana K Jones; Nanette B Fulcher; Grant J Balzer; Mark L Urbanowski; Christopher L Pritchett; Michael J Schurr; Timothy L Yahr; Matthew C Wolfgang
Journal:  J Bacteriol       Date:  2010-09-03       Impact factor: 3.490

Review 2.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

Review 3.  Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective.

Authors:  Anders Folkesson; Lars Jelsbak; Lei Yang; Helle Krogh Johansen; Oana Ciofu; Niels Høiby; Søren Molin
Journal:  Nat Rev Microbiol       Date:  2012-11-13       Impact factor: 60.633

4.  The Pseudomonas aeruginosa magnesium transporter MgtE inhibits transcription of the type III secretion system.

Authors:  Gregory G Anderson; Timothy L Yahr; Rustin R Lovewell; George A O'Toole
Journal:  Infect Immun       Date:  2009-12-22       Impact factor: 3.441

Review 5.  Clinical implications of Pseudomonas aeruginosa location in the lungs of patients with cystic fibrosis.

Authors:  J E Moore; P Mastoridis
Journal:  J Clin Pharm Ther       Date:  2017-04-04       Impact factor: 2.512

6.  Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung.

Authors:  Kalai Mathee; Oana Ciofu; Claus Sternberg; Peter W Lindum; Joan I A Campbell; Per Jensen; Anders H Johnsen; Michael Givskov; Dennis E Ohman; Molin Søren; Niels Høiby; Arsalan Kharazmi
Journal:  Microbiology       Date:  1999-06       Impact factor: 2.777

Review 7.  Fitting Pieces into the Puzzle of Pseudomonas aeruginosa Type III Secretion System Gene Expression.

Authors:  Emily A Williams McMackin; Louise Djapgne; Jodi M Corley; Timothy L Yahr
Journal:  J Bacteriol       Date:  2019-06-10       Impact factor: 3.490

8.  PtrB of Pseudomonas aeruginosa suppresses the type III secretion system under the stress of DNA damage.

Authors:  Weihui Wu; Shouguang Jin
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

9.  Effect of metabolic imbalance on expression of type III secretion genes in Pseudomonas aeruginosa.

Authors:  Arne Rietsch; Matthew C Wolfgang; John J Mekalanos
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

10.  The AlgZR two-component system recalibrates the RsmAYZ posttranscriptional regulatory system to inhibit expression of the Pseudomonas aeruginosa type III secretion system.

Authors:  Peter J Intile; Manisha R Diaz; Mark L Urbanowski; Matthew C Wolfgang; Timothy L Yahr
Journal:  J Bacteriol       Date:  2013-11-01       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.